CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 233 filers reported holding CLOVIS ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $132,000 | -35.0% | 110,900 | -1.8% | 0.00% | -50.0% |
Q2 2022 | $203,000 | -12.5% | 112,900 | -1.7% | 0.00% | 0.0% |
Q1 2022 | $232,000 | -22.1% | 114,900 | +4.5% | 0.00% | 0.0% |
Q4 2021 | $298,000 | -39.2% | 109,900 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $490,000 | -19.4% | 109,900 | +4.8% | 0.00% | -25.0% |
Q2 2021 | $608,000 | -13.3% | 104,900 | +5.0% | 0.00% | -20.0% |
Q1 2021 | $701,000 | -5.8% | 99,900 | -35.6% | 0.01% | 0.0% |
Q4 2020 | $744,000 | -16.0% | 155,100 | +2.1% | 0.01% | -28.6% |
Q3 2020 | $886,000 | -10.3% | 151,900 | +3.8% | 0.01% | -12.5% |
Q2 2020 | $988,000 | +4.0% | 146,400 | -2.0% | 0.01% | 0.0% |
Q1 2020 | $950,000 | -38.6% | 149,400 | +0.7% | 0.01% | -20.0% |
Q4 2019 | $1,547,000 | +165.4% | 148,400 | 0.0% | 0.01% | +150.0% |
Q3 2019 | $583,000 | -64.0% | 148,400 | +36.3% | 0.00% | -60.0% |
Q2 2019 | $1,619,000 | +46.0% | 108,900 | +143.6% | 0.01% | +42.9% |
Q1 2019 | $1,109,000 | +313.8% | 44,700 | +200.0% | 0.01% | +250.0% |
Q4 2018 | $268,000 | +32.0% | 14,900 | +115.9% | 0.00% | +100.0% |
Q3 2018 | $203,000 | -17.5% | 6,900 | +27.8% | 0.00% | 0.0% |
Q2 2018 | $246,000 | -81.7% | 5,400 | -78.7% | 0.00% | -87.5% |
Q1 2018 | $1,341,000 | +6.6% | 25,400 | +37.3% | 0.01% | +14.3% |
Q4 2017 | $1,258,000 | -0.9% | 18,500 | +20.1% | 0.01% | 0.0% |
Q3 2017 | $1,269,000 | +54.0% | 15,400 | +75.0% | 0.01% | +40.0% |
Q2 2017 | $824,000 | – | 8,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |